1H. Sauver and G. Sehubert - Fristschel. Breast cancer conservative and reconstrustive surgery. National libary of medicine (US),1994:34.
2Bedw inek JM,Lee JM, Fineberg M, et al. Prognostic indicators in patients with isolated total - regional recurrence of breast cancer. Cancer, 1981,47:2232.
5Reeht A ,Gray R ,Davidson NE, et al. Locoregionaln failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation:experience of the Eastern Cooperative Oncology Gyoup. J Clin Oncol, 1999; 17(6) : 1689-1700.
6Early Breast Cancer Tfialists' Collaborative Group. Systemic treatment of early cancer by hormonal, cytotoxic or immune therpy: 133 random ized trials involving 31 000 recurrences and 24 000 deaths among 75000 women . Lancet, 1992;339 (8784) : 1 - 15.
7Kaufmann M, Jonat W, Abel U, et al. Adjuvant randomized trials of doxorublcin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CM F chemotherapy versus tamoxifen in women with node positive breast cancer. J Clin Onool,1993;11 (3) :454 - 460.
8Willner J, Kiricuta IC, Kolbl O. Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma Strahlenther Onkol, 1995; 171(1) : 18 - 28.
9Rosenman J, Bernard S, Kober C, et al. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital(19701982). Cancer, 1986 ;57(7) : 1421 - 1425.
10Buzdar AU, Blumenschein GR, Smith TL, etal. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyoophosphamide,with or without irradiation in operable breast cancer:a prospective randomized trial Cancer,1984;53(3): 384 - 389.
二级参考文献1
1Leitner-sp,Swern AS,Weinberger D,et al.Predictors of recurrence for patients with small localized breast cancer[].Cancer.1995
